ROSSI, Aroldo
 Distribuzione geografica
Continente #
NA - Nord America 1.155
EU - Europa 1.021
AS - Asia 183
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.362
Nazione #
US - Stati Uniti d'America 1.152
UA - Ucraina 278
IE - Irlanda 207
SE - Svezia 181
IT - Italia 107
HK - Hong Kong 86
FI - Finlandia 61
DE - Germania 59
RU - Federazione Russa 55
VN - Vietnam 49
CN - Cina 31
GB - Regno Unito 29
FR - Francia 17
BE - Belgio 11
TR - Turchia 10
CH - Svizzera 6
PL - Polonia 5
UZ - Uzbekistan 5
CA - Canada 3
ES - Italia 2
EU - Europa 2
LB - Libano 2
NL - Olanda 2
AR - Argentina 1
RO - Romania 1
Totale 2.362
Città #
Chandler 264
Dublin 207
Jacksonville 154
San Mateo 134
Hong Kong 86
Ann Arbor 68
Medford 53
Princeton 53
Dong Ket 49
Altamura 42
Wilmington 38
Ashburn 37
Lawrence 31
Beijing 26
Perugia 26
Andover 23
Des Moines 21
Saint Petersburg 20
Woodbridge 14
Boardman 12
Brussels 11
Izmir 10
Helsinki 8
Norwalk 7
San Paolo di Civitate 7
Auburn Hills 5
Bari 5
Frankfurt Am Main 4
Moscow 4
New York 4
Shanghai 4
Los Angeles 3
Marrùbiu 3
Montemesola 3
Ottawa 3
Trieste 3
Den Haag 2
Foligno 2
Madrid 2
Redmond 2
San Diego 2
Centrale 1
Chicago 1
Fremont 1
Genova 1
Houston 1
Isidro Casanova 1
Kiev 1
Marseille 1
Milan 1
Modena 1
Nanning 1
Paris 1
Philadelphia 1
Piossasco 1
Redwood City 1
San Giuliano Milanese 1
Stella Cilento 1
Tappahannock 1
Terni 1
Totale 1.471
Nome #
Botulinum toxin versus lidocaine in the treatment of myofacial pain: a double blind randomized study 86
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 85
A multidiscilinary method for a successful aging 81
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 77
Neurobiotica: studio multidisciplinare per il recupero delle funzioni cerebrali 73
Disturbi dell'equilibrio nei pazienti con cefalea primaria: entità reale o soggettiva? Valutazione qualitativa e quantitativa mediante stabilometria statica - Atti XVI Conresso Nazionale "Cefalee ed età della vita" 70
Tossina botulinica: nuove possibilità di impiego 67
Acute dystonia induced by the combination of midodrine and perphenazine. 65
A unique association of Marfan syndrome with craniofacial hypoplasia, oligophrenia and severe microphthalmia. 62
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 62
Clinical aspects and management of levodopa-induced dyskinesia. 61
Demenza e pseudodemenza: utilità dei criteri diagnostici 59
Balance disorders in headache patients: evaluation by computerized static stabilometry 57
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 56
Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder. 55
A magnetization transfer study of mild and advanced Parkinson's disease. 54
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. 52
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 51
Creatine kinase BB activity in serum of patients with acute stroke: correlation with the severity of brain damage. 51
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 49
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 47
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 46
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 44
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 42
Modificazioni del nervo sciatico nel ratto indotte da diete lipidiche. 41
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. 41
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 41
Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. 41
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 39
Multimodal use of computed tomography in early acute stroke 38
The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. 38
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease 38
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 38
Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease. 37
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. 37
Botulinum A toxin intravesical injection in patients with Parkinson’ s disease and Multiple System Atrophy with overactive bladder syndrome and detrusor overactivity. 37
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 36
Hot water epilepsy and Mccune-Albright syndrome: a case report. 35
Tappe dello sviluppo cerebrale in relazione alla disponibilità di nutrienti a partire dall'australopiteco 35
The endocannabinoid system in Parkinson's disease. 34
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study 34
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease. 34
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 34
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed atrofia multi- sistemica. 32
A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline 32
The Brain Dopaminergic System and Hyperthermia: The Neuroleptic Malignant Syndrome and The Parkinsonism-hyperpyrexia Syndrome 31
CSF Biomarkers in Parkinson's disease 30
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 30
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 29
Il trattamento della sclerosi multipla 28
Iodine- Iodine-123-N-omega-fluoropropyl fluoropropyl fluoropropyl-2beta-carbomethoxy carbomethoxy carbomethoxy-3beta-(4- iodophenyl)- iodophenyl)-nortropane nortropane nortropane brain SPET with brain SPET with brain SPET with semiquantitative analysis in semiquantitative analysis in Parkinson’s disease as evaluated by support vector machine classifier: diagnostic performance and influence of age diagnostic performance and influence of age 26
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 25
Disturbi dell'equilibrio in pazienti con mcefalea: diversi meccanismi patogenetici? 24
Totale 2.447
Categoria #
all - tutte 8.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 4 14 0
2019/2020244 6 6 42 2 41 2 44 4 46 26 4 21
2020/2021546 5 42 22 45 147 34 42 2 72 21 56 58
2021/2022428 13 95 12 28 14 1 2 134 4 9 51 65
2022/2023787 59 145 14 71 68 84 0 33 277 3 23 10
2023/2024193 23 22 17 10 2 4 46 14 53 2 0 0
Totale 2.447